As we age, plaque can build up inside the heart’s arteries, eventually reducing or blocking the flow of blood. Abbott offers leading treatments for coronary artery disease, including an extensive range of drug-eluting stents, bare metal stents, balloon dilatation catheters, and other minimally invasive devices.

Arteries outside of the heart – in the legs, abdomen, arms, and neck, for example – can become obstructed by plaque and have reduced blood flow. Our full range of minimally invasive peripheral stents, guide wires and dilatation catheters open blockages in the arteries caused by plaque build-up to help people regain an active life.

From transcatheter and surgical valves to structural interventions, the Abbott Structural Heart portfolio spans a wide range of life-changing technologies. Our vision and leadership in mitral and tricuspid solutions enable us to push the boundaries in developing solutions for undertreated conditions. Moreover the depth and breadth of our experience—paired with our proven therapy solutions—provide the means to help physicians address structural heart patient needs at every stage of living.

Abbott heart failure management products are designed to address the continuum of care, from monitoring for symptoms to advanced stage therapy. We have dedicated our efforts to providing you with the broadest scope of technologically innovative, clinically proven and outcome-driven solutions for better heart failure management. Our vision is to transform the treatment of heart failure by designing technology that delivers excellent clinical outcomes and improves workflow and efficiency.